Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT and/or Fluoxetine for Hypochondriasis
NCT00339079Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2006
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in illness anxiety disorder (IAD), sponsored by Brigham and Women's Hospital. Started Jun 2006; status: completed.
02
Drugs
fluoxetine
03
Conditions
illness anxiety disorder (IAD)
Beyond the preview
Go deeper on NCT00339079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00339079.